Ignite Creation Date:
2024-05-05 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 9:40 AM
Study NCT ID:
NCT00587054
Status:
COMPLETED
Last Update Posted:
2017-03-10
First Post:
2007-12-21
Brief Title:
Trial of Allogeneic Stem Cell Transplants From HLA Compatible Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Organization Data
Organization:
Memorial Sloan Kettering Cancer Center
Class:
OTHER
Study ID:
01-070
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |